Adverse events reported by study participants
Adverse event | SLE (N=50) | Controls (N=50) | Total (N=100) |
---|---|---|---|
Erythema and pain at injection site | 3 (6%) | 2 (4%) | 5 (5%) |
Rash | 1 (2%) | 0 (0%) | 1 (1%) |
Nausea | 1 (2%) | 0 (0%) | 1 (1%) |
Headache | 1 (2%) | 1 (2%) | 2 (2%) |
Irregular menses | 1 (2%) | 1 (2%) | 2 (2%) |
Upper respiratory tract infection | 1 (2%) | 1 (2%) | 2 (2%) |
SLE, systemic lupus erythematosus.